| Literature DB >> 30811776 |
Abstract
Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.Entities:
Keywords: Turner syndrome; growth; growth hormone
Mesh:
Substances:
Year: 2019 PMID: 30811776 DOI: 10.1002/ajmg.c.31680
Source DB: PubMed Journal: Am J Med Genet C Semin Med Genet ISSN: 1552-4868 Impact factor: 3.908